Factor XI Antibodies

Santa Cruz Biotechnology offers a broad range of Factor XI monoclonal antibodies for research in coagulation and hemostasis. Factor XI monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Factor XI is a crucial component of the intrinsic pathway of blood coagulation, playing a significant role in the activation of thrombin and the formation of fibrin. Understanding Factor XI function is essential for investigating bleeding disorders and thrombotic diseases. Research focusing on Factor XI mechanisms can lead to breakthroughs in treating conditions such as deep vein thrombosis and stroke. Factor XI studies continue to reveal new aspects of blood coagulation pathways and their regulation. Investigating Factor XI's role in hemostasis opens new possibilities for therapeutic development. Factor XI monoclonal antibodies enable researchers to explore complex biological processes and advance scientific understanding of blood coagulation disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to advance medical knowledge and develop innovative treatments for coagulation-related diseases.